MIGVAX
MigVax is an Israeli medical technology startup.
MIGVAX
Industry:
Health Care Pharmaceutical
Founded:
2020-01-01
Address:
Misgav, HaZafon, Israel
Country:
Israel
Website Url:
http://www.migvax.com
Total Employee:
1+
Status:
Active
Contact:
+972-4-6953511
Total Funding:
16.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro COVID-19 Wix
Similar Organizations
Healthwire
Healthwire is a health-tech startup.
Current Employees Featured
Ronald Ellis Chief Technology Officer @ MigVax
Chief Technology Officer
David Zigdon Chief Executive Officer @ MigVax
Chief Executive Officer
2020-03-01
Investors List
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Grant - MigVax
OurCrowd
OurCrowd investment in Venture Round - MigVax
Official Site Inspections
http://www.migvax.com Semrush global rank: 7.92 M Semrush visits lastest month: 410
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147

More informations about "MigVax"
Covid-19 Vaccine Development by Migvax, MIGAL SPV
Current commercial COVID-19 vaccines are mostly injectable. Injectables present logistical and technical challenges. Optimal protection at virus’ mucosal entry points may be lacking with …See details»
About - MigVax
Recognized as a powerhouse of applied research, for forty years MIGAL has cooperated closely with industry leaders, innovative startups, and technological accelerators.See details»
CEPI announces first funding awards in quest to develop ‘variant …
Nov 4, 2021 · CEPI will support researchers at two institutions, MigVax Ltd, Israel, and the University of Saskatchewan's (USask) Vaccine and Infectious Disease Organization (VIDO), …See details»
CEPI funds consortium led by CPI to advance Caltech's …
MigVax Ltd— funding of US$4.3m to MigVax Ltd to support the initial development of a new orally administered subunit vaccine tablet that could offer broad protection against SARS-CoV-2 variantsSee details»
MigVax - Crunchbase Company Profile & Funding
MigVax is an Israeli medical technology startup. An oral COVID-19 subunit vaccine that generates mucosal, blood-based, and cell-mediated immunity using a chimeric protein. A proprietary …See details»
CEPI partners with Intravacc to develop an intranasal, broadly ...
Oct 6, 2022 · CEPI will provide seed funding of up to US$4.8 million to Intravacc - a world leader in translational research and development of preventive and therapeutic vaccines - to advance …See details»
Israel’s MigVax Receives $4.3M Award For …
Nov 7, 2021 · Israel’s MigVax, the affiliate company established by Israeli scientists at the Migal Galilee Research Institute to develop a vaccine for the coronavirus, has received a $4.3 million award from Norway’s Coalition of …See details»
Israeli Covid vaccine tablet receives $4.3 million in funding
A coalition funded by Bill Gates dedicated to fighting Covid awarded $4.3 million to an Israeli company for development of a variant-proof vaccine that comes in tablet form. The Coalition for...See details»
MigVax - LinkedIn
MigVax is a startup developing Migvax-101, a novel oral subunit COVID-19 vaccine that has demonstrated effectivity in pre-clinical tests as a booster for previously vaccinated persons. MigVax...See details»
Pan-coronavirus vaccine pipeline takes form - Nature
Leading the charge, the Coalition for Epidemic Preparedness Innovations (CEPI) and the US National Institute of Allergy and Infectious Diseases (NIAID) have earmarked US$200 million …See details»
MigVax Ltd. | Bill & Melinda Gates Foundation
MigVax Ltd. Committed grants. More in this section Committed grants. MigVax Ltd. Grantee website Israel Purpose. to support early evaluation of a novel technology that could be used …See details»
Front-Runners in the Race for Variant-Proof and All-Coronavirus ...
Jul 9, 2022 · This oral vaccine is a protein subunit vaccine, called MigVax-101. MigVax-101 is based on the developers’ vaccine developed to prevent avian IBV (Infectious Bronchitis Virus) …See details»
Beyond COVID-19: the promise of next-generation coronavirus …
Aug 22, 2024 · In this review, we aim to provide a detailed overview of the features of CoVs, their phylogeny, current vaccines against various CoVs, the efforts in developing broad-spectrum …See details»
MigVax-101 - Wikipedia
MigVax-101 is a COVID-19 vaccine candidate developed by Oravax Medical. [1] [2] [3]See details»
Israeli oral virus vaccine proven effective as booster in preclinical trial
Jun 10, 2021 · MigVax Ltd., an Israeli startup company developing an oral subunit vaccine against coronavirus, announced Thursday that preclinical trials yielded promising results that …See details»
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing
Jun 9, 2021 · MigVax-101 is a multi-epitope oral vaccine for SARS-CoV-2. MigVax-101 serves as an effective booster in rats to a parenteral anti-S1 vaccine. The authors are in collaboration …See details»
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing …
Feb 2, 2022 · Similarly, two oral MigVax-101 doses after two injections were associated with non-significant increase in anti-S1 IgA levels as compared to two injections followed by two oral …See details»
Pan-coronavirus vaccine pipeline takes form - Nature
Apr 19, 2022 · One, from MigVax, is orally administered with a bacterial toxin serving as a mucosal adjuvant. Another, from Affinivax, is built around an antigen–polysaccharide …See details»
ONNX | 首页 - ONNX 开放神经网络交换
Onnx 是一种用于表示机器学习模型的开放格式。 onnx 定义了一组通用的运算符 - 机器学习和深度学习模型的构建块 - 以及一个通用的文件格式,使 ai 开发人员能够使用各种框架、工具、运 …See details»
Oral subunit SARS-CoV-2 vaccine induces systemic ... - ScienceDirect
Feb 16, 2022 · MigVax-101 is a multi-epitope oral vaccine for SARS-CoV-2. • MigVax-101 elicits neutralizing IgG and IgA production and cellular responses in mice. • MigVax-101 serves as …See details»